Yageo Corporation (LUX:YAGEO)

Market Cap	8.07B
Revenue (ttm)	3.46B
Net Income (ttm)	564.39M
Shares Out	n/a
EPS (ttm)	0.27
PE Ratio	14.30
Forward PE	12.51
Dividend	2.33 (2.59%)
Ex-Dividend Date	Jun 13, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	90.00
Day's Range	n/a
52-Week Range	57.07 - 99.63
Beta	n/a
RSI	58.08
Earnings Date	Jul 25, 2025

About Theseus Pharmaceuticals

Yageo Corporation, together with its subsidiaries, engages in the manufacture and sale of electronic components in China, Europe, the United States, and rest of Asia. It offers chip resistors, including automotive, current sensing, anti-sulfurated, thin film, thick film precision and general purpose, array/network, high voltage, surge, high temperature, lead free, Ni/Au termination, RF attenuator, and trimmable; and MLCCs, such as general purpose, automotive, high frequency, soft termination, miniaturization, array, and low inductance. The comp...

• Industry: Electronic Components And Accessories
• Founded: 1977
• Employees: 40,000
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: YAGEO

Financial Performance

In 2024, Yageo's revenue was 121.67 billion, an increase of 13.06% compared to the previous year's 107.61 billion. Earnings were 19.36 billion, an increase of 11.07%.